Novartis Says U.S. FTC Seeks More Information on Hexal Acquisition

Novartis AG, said the US Federal Trade Commission on April 6 requested more information on its planned acquisition of generic drugmakers Eon Labs Inc of the US and Germany's Hexal AG. The Swiss pharmaceuticals group such a second request for additional information, which extends the waiting period on completion of the deal by 30 days, is not unusual in transactions of this magnitude and nature. The buyout of publicly-held shares of Eon Labs will run in coordination with the regulatory process, it said.

Sharewatch (http://www.sharewatch.com/story.php?storynumber=71188)